Recent insights and therapeutic perspectives of angiotensin-(1–9) in the cardiovascular system
Ocaranza MP ., Michea L., Chiong M., Lagos C., Lavandero S ., Jalil J.
Reply: dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure.
Ocaranza MP. , Michea L., Chiong M., Lavandero S. , Jalil JE.
Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway
Parra V., Verdejo H ., Iglewski M., Del Campo A., Troncoso R . ,Jones D., Zhu Y., Kuzmicic J., Pennanen C., Lopez-Crisosto C. , Jana F., Ferreira J., Noguera E., Chiong M. , Bernlohr D., Klip A., Hill J., Rothermel B., Abel E. , Lavandero S.
Effects of trimetazidine in nonischemic heart failure: a randomized study
Winter JL., Castro PF ., Quintana JC., Altamirano R., Enriquez A., Verdejo HE. , Jalil JE., Mellado R., Concepcion R., Sepulveda P., Rossel V., Sepulveda L., Chiong M., Lavandero S .
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
Ocaranza MP ., Moya J., Barrientos V., Alzamora R. ,Hevia D., Morales C., Pinto M., Escudero N., Garcia L ., Novoa U., Ayala P. , Diaz-Araya G. , Godoy I., Chiong M., Lavandero S ., Jalil JE., Michea L.
Tumor suppression and promotion by autophagy
Avalos Y., Canales J., Bravo-Sagua R., Criollo A., Lavandero S., Quest A.
